???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Filipe Manuel Farto Palavra

Nomes de citação

  • Palavra, Filipe

Identificadores de autor

Ciência ID
C91F-BF0C-757A
ORCID iD
0000-0002-2165-130X

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Clínica - Neurologia Clínica

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Português Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Espanhol; Castelhano Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Francês Utilizador elementar (A1) Utilizador independente (B1) Utilizador elementar (A1) Utilizador elementar (A1)
Formação
Grau Classificação
2016 - 2018
Concluído
 Special Studies in Pediatric Neurology (Título de especialista)
Especialização em Neuropediatria
Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2012
Concluído
 Neurology Clinical Internship (Título de especialista)
Centro Hospitalar e Universitário de Coimbra EPE, Portugal
"Neurology Residency" (TESE/DISSERTAÇÃO)
 20 valores
2005
Concluído
 Medicine Licenciature (Licenciatura)
Universidade de Coimbra Faculdade de Medicina, Portugal
"N/A" (TESE/DISSERTAÇÃO)
 17.18 valores
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2011/07/28 - Atual Assistente Convidado (Docente Universitário) Universidade de Coimbra Faculdade de Medicina, Portugal
2009 - Atual Assistente Convidado (Docente Universitário) CNC.IBILI, Portugal
2009/10/01 - 2011/12/30 Assistente Convidado (Docente Universitário) Universidade de Coimbra Faculdade de Medicina, Portugal

Outras Carreiras

Categoria Profissional
Instituição de acolhimento 		Empregador
2023/08/31 - Atual Assistente graduado (Médica) Centro Hospitalar e Universitário de Coimbra EPE, Portugal
Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2016 - 2018 Assistente (Médica) CNC.IBILI, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2016/01/05 - Atual Pediatric Neurologist Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2012/09/17 - Atual PhD Student Universidade de Coimbra Faculdade de Medicina, Portugal
2009/09/21 - Atual Invited teacher (Neurology) Instituto Politécnico de Viseu Escola Superior de Saúde de Viseu, Portugal
2014/09/01 - 2015/12/31 Médico e Investigador Clínico Universidade de Coimbra Instituto de Ciências Nucleares Aplicadas à Saúde, Portugal
2013/01/01 - 2014/08/29 Clinical Research Fellow Hospital Vall d'Hebron, Espanha
2007/09/17 - 2012/07/31 Invited teacher (Neurology) Escola Superior de Enfermagem de Coimbra, Portugal
2007/01/01 - 2012/04/30 Neurology Resident Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2007/09/17 - 2009/07/31 Invited teacher (Neurology Sessions for Clinical Psychologists) Universidade de Coimbra Faculdade de Psicologia e de Ciências da Educação, Portugal
2006/01/02 - 2006/12/31 Common Year Resident (undiferentiated rotation) Hospitais da Universidade de Coimbra, Portugal
1999/10/18 - 2005/07/29 Medicine student Universidade de Coimbra Faculdade de Medicina, Portugal
Produções

Publicações

Artigo em revista
  1. Carolina Folques; Liza Aguiar; Ana Luisa Carvalho; Catarina Paiva; Patricia Dias; Mariana Soeiro Sa; Jose Paulo Monteiro; Filipe Palavra. "The role of NACC1 c.892C>T (p.Arg298Trp) variant in a neurodevelopmental disorder: report of two new cases". Pediatric Oncall 22 4 (2025): http://dx.doi.org/10.7199/ped.oncall.2025.43.
    10.7199/ped.oncall.2025.43
  2. Mafalda Ferreira dos Santos; Mário Laço; Conceição Robalo; Filipe Palavra. "Unverricht-Lundborg Disease: Tackling the Challenges of a Complex Clinical Picture". Sinapse (2024): https://doi.org/10.46531/sinapse/CC/220078/2023.
    10.46531/sinapse/CC/220078/2023
  3. Ana Rita Rodrigues; Filipe Palavra; Victoria Bell; Filipa Mascarenhas-Melo; Luis Almeida; Francisco Veiga. "Depression in the Paediatric Population: Current Therapeutic Context and Challenges to Innovation". Sinapse (2024): https://doi.org/10.46531/sinapse/AR/230029/2023.
    10.46531/sinapse/AR/230029/2023
  4. Helena Donato; Filipe Palavra; Catarina Resende de Oliveira. "Sinapse: Current Analysis and Future Perspectives". Sinapse (2024): https://doi.org/10.46531/sinapse/ED/230087/2023.
    10.46531/sinapse/ED/230087/2023
  5. Filipe Palavra; Leonor Geria; André Jorge; Margarida Marques; Constança Soares dos Santos; Joana Amaral; Joana Afonso Ribeiro; Cristina Pereira; Conceição Robalo. "Neutrophil/lymphocyte and monocyte/lymphocyte indexes as potential predictors of relapse at 1 year after diagnosis of pediatric multiple sclerosis: a single-center, exploratory and proof-of-concept study". Frontiers in Neuroscience 17 (2024): http://dx.doi.org/10.3389/fnins.2023.1305176.
    10.3389/fnins.2023.1305176
  6. Inês V. Carvalho; Constança Soares dos Santos; Joana Amaral; Joana Afonso Ribeiro; Cristina Pereira; Rui Pedro Pais; Filipe Palavra. "Multiple sclerosis under the age of ten: the challenge of a rare diagnosis in a special population – a case series". Frontiers in Neuroscience 17 (2023): http://dx.doi.org/10.3389/fnins.2023.1297171.
    10.3389/fnins.2023.1297171
  7. Filipe Palavra; Diogo Silva; Catarina Fernandes; Ricardo Faustino; Mónica Vasconcelos; Cristina Pereira; Carmen Costa; et al. "Clinical predictors of NEDA-3 one year after diagnosis of pediatric multiple sclerosis: an exploratory single-center study". Frontiers in Neuroscience 17 (2023): http://dx.doi.org/10.3389/fnins.2023.1259306.
    10.3389/fnins.2023.1259306
  8. Ana Margarida Pinto; Mariana Luís; Rinie Geenen; Filipe Palavra; Mark A. Lumley; Jacob N. Ablin; Kirstine Amris; et al. "Neurophysiological and psychosocial mechanisms of fibromyalgia: A comprehensive review and call for an integrative model". Neuroscience & Biobehavioral Reviews 151 (2023): 105235-105235. http://dx.doi.org/10.1016/j.neubiorev.2023.105235.
    10.1016/j.neubiorev.2023.105235
  9. Carolina Maia; Joana Pinto; Sílvia Carvalho; Alice Carvalho; Filipe Palavra. "Tumor Recurrence versus Radiation-induced Stroke in a Child with a History of Medulloblastoma". Sinapse (2023): https://doi.org/10.46531/sinapse/CC/220076/2023.
    10.46531/sinapse/CC/220076/2023
  10. Beatriz Garrido; Joana Afonso Ribeiro; Filipe Palavra. "Branaplam as a Promising Splicing Modulator: From Spinal Muscular Atrophy to Huntington’s Disease". Sinapse (2023): https://doi.org/10.46531/sinapse/AR/230005/2023.
    10.46531/sinapse/AR/230005/2023
  11. A.A. Tamborska; G.K. Wood; E. Westenberg; D. Garcia-Azorin; G. Webb; N. Schiess; M. Netravathi; et al. "Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study". Journal of the Neurological Sciences 449 (2023): 120646-120646. http://dx.doi.org/10.1016/j.jns.2023.120646.
    10.1016/j.jns.2023.120646
  12. Ana Margarida Pinto; Rinie Geenen; TOR WAGER; Winfried Häuser; Eva Kosek; Jacob N. Ablin; Kirstine Amris; et al. "Reply to: Hypothetical model ignores many important pathophysiologic mechanisms in fibromyalgia". Nature Reviews Rheumatology 19 5 (2023): 322–323-322–323. http://dx.doi.org/10.1038/s41584-023-00952-2.
    10.1038/s41584-023-00952-2
  13. Ana Margarida Pinto; Rinie Geenen; Tor D. Wager; Mark A. Lumley; Winfried Häuser; Eva Kosek; Jacob N. Ablin; et al. "Reply to ‘Imbalance of threat and soothing systems in fibromyalgia: rephrasing an established mechanistic model?’". Nature Reviews Rheumatology 19 5 (2023): 319–320-319–320. http://dx.doi.org/10.1038/s41584-023-00950-4.
    10.1038/s41584-023-00950-4
  14. Laura Correia. "Torcicolo Adquirido em Idade Pediátrica: Uma Manifestação Clínica com um Amplo Espetro de Gravidade". Sinapse 23 1 (2023): 42–46-42–46. http://dx.doi.org/10.46531/sinapse/cc/220068/2023.
    10.46531/sinapse/cc/220068/2023
  15. Raquel Gil-Gouveia. "Serviços de Saúde em Cefaleias em Portugal – 2022: Resultado de Inquérito pela Sociedade Portuguesa de Cefaleias". Sinapse 23 1 (2023): 6–14-6–14. http://dx.doi.org/10.46531/sinapse/ao/230017/2023.
    10.46531/sinapse/ao/230017/2023
  16. Teresa Almeida Lopes. "Atypical Cerebellar Involvement in MOG Antibody-Associated Disease (MOGAD) in Early Childhood". Sinapse 23 1 (2023): 60–61-60–61. http://dx.doi.org/10.46531/sinapse/in/230001/2023.
    10.46531/sinapse/in/230001/2023
  17. Teresa Botelho. "Is it Guillain-Barré Syndrome with Extense Leptomenigeal Enhancement?". Sinapse 22 4 (2023): 184–185-184–185. http://dx.doi.org/10.46531/sinapse/in/220064/2022.
    10.46531/sinapse/in/220064/2022
  18. Ana Margarida Pinto; Rinie Geenen; TOR WAGER; Mark A. Lumley; Winfried Häuser; Eva Kosek; Jacob N. Ablin; et al. "Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia". Nature Reviews Rheumatology 19 1 (2022): 44–60-44–60. http://dx.doi.org/10.1038/s41584-022-00873-6.
    10.1038/s41584-022-00873-6
  19. Joana Afonso Ribeiro; Mário Sousa; Isabel Alonso; Fradique Moreira; Ricardo Pereira; Filipe Palavra. "PRKRAP1 Pseudogene Complicating the Diagnosis of Young-Onset Dystonia Due to PRKRA Gene Disease-Causing Variants (DYT-PRKRA)". Movement Disorders Clinical Practice (2022): https://doi.org/10.1002/mdc3.13426.
    10.1002/mdc3.13426
  20. Inês Gomes; Joana Jesus Ribeiro; Filipe Palavra. "Monitoring and Managing Patients with Tuberous Sclerosis Complex: Current State of Knowledge". Journal of Multidisciplinary Healthcare (2022): https://doi.org/10.2147/JMDH.S266990.
    10.2147/JMDH.S266990
  21. Filipe Palavra; Sofia D. Viana; Sara Henriques; João Dinis; João Martins; Maria H. Madeira; Raquel Santiago; et al. "Defining milestones for the study of remyelination using the cuprizone mouse model: How early is early?". Multiple Sclerosis and Related Disorders (2022): https://doi.org/10.1016/j.msard.2022.103886.
    10.1016/j.msard.2022.103886
  22. Gonçalo Favinha. "Immunotherapy in Pediatric Guillain-Barré Syndrome: Intravenous Immunoglobulin, Plasmapheresis, Both or Something Else?". Sinapse 22 2 (2022): 74–82-74–82. http://dx.doi.org/10.46531/sinapse/ar/220002/2022.
    10.46531/sinapse/ar/220002/2022
  23. Ricardo Faustino; Miguel Faria; Mónica Teixeira; Filipe Palavra; Paulo Sargento; Maria do Céu Costa. "Systematic review and meta-analysis of the prevalence of coronavirus: One health approach for a global strategy". One Health 14 (2022): 100383-100383. http://dx.doi.org/10.1016/j.onehlt.2022.100383.
    10.1016/j.onehlt.2022.100383
  24. "Coats-plus syndrome: when imaging leads to genetic diagnosis". BMJ Case Reports 15 5 (2022): e249702-e249702. http://dx.doi.org/10.1136/bcr-2022-249702.
    10.1136/bcr-2022-249702
  25. Joana Silva; Ricardo Faustino; Filipe Palavra. "Síndrome Radiológica Isolada em Idade Pediátrica: O Modelo Clínico Ideal para o Estudo da Remielinização?". Sinapse 22 1 (2022): 16-23. https://doi.org/10.46531/sinapse/AR/210032/2022.
    10.46531/sinapse/AR/210032/2022
  26. Cecília Martins; João Moura; Sónia Figueiroa; Cristina Garrido; Joana Martins; Raquel Samões; Joana Guimarães; et al. "Pediatric neuromyelitis optica spectrum disorders in Portugal: A multicentre retrospective study". Multiple Sclerosis and Related Disorders 59 (2022): 103531-103531. http://dx.doi.org/10.1016/j.msard.2022.103531.
    10.1016/j.msard.2022.103531
  27. "Cefalea trigémino-autonómica secundaria pediátrica: la rareza existe". Anales de Pediatría (2022): http://dx.doi.org/10.1016/j.anpedi.2021.12.002.
    10.1016/j.anpedi.2021.12.002
  28. Ernestina Santos; Ana Luísa Rocha; Vanessa Oliveira; Daniela Ferro; Raquel Samões; Ana Paula Sousa; Sónia Figueiroa; et al. "Neuromyelitis optica spectrum disorders: A nationwide Portuguese clinical epidemiological study". Multiple Sclerosis and Related Disorders 56 (2021): 103258-103258. http://dx.doi.org/10.1016/j.msard.2021.103258.
    10.1016/j.msard.2021.103258
  29. Alexandra Dias da Silva. "Acute Demyelinating Syndrome in a Child: When a Poor Evolution Suggests Combined Central and Peripheral Involvement". Sinapse 21 3 (2021): 185–187-185–187. http://dx.doi.org/10.46531/sinapse/cc/210023/2021.
    10.46531/sinapse/cc/210023/2021
  30. Jorge Costa. "Canabinóides no Tratamento da Epilepsia em Idade Pediátrica: Uma Revisão Sistemática". Sinapse 21 3 (2021): 170–179-170–179. http://dx.doi.org/10.46531/sinapse/rs/210034/2021.
    10.46531/sinapse/rs/210034/2021
  31. Sofia Grenho Rodrigues; Daniela Vieira; Francisco Bernardo; Joana Coelho; Joana Afonso Ribeiro; Filipe Palavra; Conceição Robalo; António Levy; Sofia Quintas. "Pediatric cerebral sinus venous thrombosis: clinical characterization of a Portuguese cohort". Acta Neurologica Belgica 122 5 (2021): 1211–1218-1211–1218. http://dx.doi.org/10.1007/s13760-021-01807-x.
    10.1007/s13760-021-01807-x
  32. Anabela Marisa Azul; Ricardo Almendra; Marta Quatorze; Adriana Loureiro; Flávio Reis; Rui Tavares; Anabela Mota-Pinto; et al. "Unhealthy lifestyles, environment, well-being and health capability in rural neighbourhoods: a community-based cross-sectional study". BMC Public Health 21 1 (2021): http://dx.doi.org/10.1186/s12889-021-11661-4.
    10.1186/s12889-021-11661-4
  33. Filipe Palavra. "Cristalizações e Digitalizações: A Sociedade Portuguesa de Neurologia Rumo ao Desconfinamento". Sinapse (2021): https://doi.org/10.46531/sinapse/ED/210046.
    10.46531/sinapse/ED/210046
  34. Raquel Gil-Gouveia. "Organização de Serviços de Apoio Clínico para Doentes com Cefaleias em Portugal". Sinapse 21 2 (2021): 112–120-112–120. http://dx.doi.org/10.46531/sinapse/gu/200034/2021.
    10.46531/sinapse/gu/200034/2021
  35. Bruno Silva. "Migraine with Aura After Endovascular Treatment of a Vertebro-Vertebral Fistula: Difficulties with Headache Classification". Sinapse 21 2 (2021): 103–106-103–106. http://dx.doi.org/10.46531/sinapse/cc/210006/2021.
    10.46531/sinapse/cc/210006/2021
  36. Constança Soares dos Santos; Bruno Costa Gomes; Filipe Palavra. "Multiple sclerosis with pseudotumoral demyelinating lesions in a female adolescent presenting with an optic neuritis". BMJ Case Reports (2021): https://doi.org/10.1136/bcr-2021-244837.
    10.1136/bcr-2021-244837
  37. Elsa Parreira. "Recomendações Terapêuticas para Cefaleias da Sociedade Portuguesa de Cefaleias – 2021". Sinapse 21 supplement (2021): 3–100-3–100. http://dx.doi.org/10.46531/sinapse/gu/200048/2021.
    10.46531/sinapse/gu/200048/2021
  38. Simona Sacco; On behalf of the Burden and Attitude to Resistant and Refractory (BARR) Study Group; Christian Lampl; Antoinette Maassen van den Brink; Valeria Caponnetto; Mark Braschinsky; Anne Ducros; et al. "Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance". The Journal of Headache and Pain 22 1 (2021): http://dx.doi.org/10.1186/s10194-021-01252-4.
    10.1186/s10194-021-01252-4
  39. Lenz B; Katsarava Z; Gil-Gouveia R; Karelis G; Kaynarkaya B; Meksa L; Oliveira E; et al. "Headache service quality evaluation: implementation of quality indicators in primary care in Europe.". The journal of headache and pain (2021): http://europepmc.org/abstract/med/33910500.
    10.1186/s10194-021-01236-4
  40. Catarina Fernandes. "Pediatric Multiple Sclerosis Before the PARADIGMS Study: Nine Years of Experience in a Portuguese Tertiary Center". Sinapse 21 1 (2021): 33-39. https://doi.org/10.46531%2Fsinapse%2Fao%2F200062%2F2021.
    10.46531/sinapse/ao/200062/2021
  41. "TyPed study: Natalizumab for the treatment of pediatric-onset multiple sclerosis in Portugal". Multiple Sclerosis and Related Disorders (2021):
    https://doi.org/10.1016/j.msard.2021.102865
  42. Sara De Carvalho; Joana Pinto; Inês Correia; Ricardo Faustino; Mónica Vasconcelos; Lívia Sousa; Filipe Palavra. "Inflammatory Activity and Treatment Response in Pediatric Compared to Adult Multiple Sclerosis: A Pilot, Retrospective and Observational Study of the First Year After Diagnosis". Acta Médica Portuguesa (2021): https://doi.org/10.20344/amp.12486.
    10.20344/amp.12486
  43. "Sintomatologia Psiquiátrica como Manifestação Primária de Esclerose Múltipla Pediátrica: Revisão Sistemática da Literatura". Sinapse (2020):
    10.46531/sinapse/AR/200050/2020
  44. "A Novel ACTA2 Gene Disease-Causing Variant Presenting with a Complex Brain Phenotype". Sinapse (2020):
    10.46531/sinapse/CC/200032/2020
  45. "Revista Sinapse: Onde Estamos e Para Onde Pretendemos Ir?". Sinapse (2020):
    https://doi.org/10.46531/sinapse/ed/210003
  46. "Headache – what service do we provide? Evaluation of quality indicators in primary health-care units". Sinapse (2020):
    10.46531/sinapse/AO/200047/2020
  47. "Péptido Relacionado com o Gene da Calcitonina (CGRP) e SARS-CoV-2". Sinapse 20 2 (2020): 30-33. http://dx.doi.org/10.46531/sinapse/ar/covid19/palavraf/2020.
    10.46531/sinapse/ar/covid19/palavraf/2020
  48. "Hypotonia: A Clinical Sign, Different Etiologies". Portuguese Journal of Pediatrics (former Acta Pediátrica Portuguesa) (2020): Vol. 51 No. 3 (2020)-Vol. 51 No. 3 (2020). https://pjp.spp.pt//article/view/18651.
    10.25754/PJP.2020.18651
  49. "Estudo da enxaqueca em idade pediátrica nos cuidados de saúde primários da região Centro de Portugal". Sinapse 20 1 (2020): 9-16. http://dx.doi.org/10.46531/sinapse/2020/ao/200007/2020.
    10.46531/sinapse/2020/ao/200007/2020
  50. "Cefaleia e Doença Celíaca: O Que Há em Comum?". Sinapse 20 1 (2020): 71-75. http://dx.doi.org/10.46531/sinapse/cc/190027/2020.
    10.46531/sinapse/cc/190027/2020
  51. "Chronic headache in adolescence: is there a place for medication overuse?". Sinapse 20 1 (2020): 55-59. http://dx.doi.org/10.46531/sinapse/2020/cc/190033/2020.
    10.46531/sinapse/2020/cc/190033/2020
  52. "Pediatric Miller-Fisher Syndrome: clinical features and diagnostic challenges". Sinapse 20 1 (2020): 46-50. http://dx.doi.org/10.46531/sinapse/2020/cc/190008/2020.
    10.46531/sinapse/2020/cc/190008/2020
  53. Duarte Armindo R; Pinto J; Pereira C; Vasconcelos M; Palavra F. "Unilateral Optic Neuritis in Children: Experience of a Tertiary Centre.". European neurology (2020): http://europepmc.org/abstract/med/32570233.
    10.1159/000508070
  54. Rui Duarte Armindo. "The spectrum of anti-MOG associated demyelinating diseases in children: a review illustrated with clinical cases". Sinapse 20 1 (2020): 17-27. https://doi.org/10.46531%2Fsinapse%2F2020%2Far%2F200007%2F2020.
    10.46531/sinapse/2020/ar/200007/2020
  55. "Insights into Autoimmune Movement Disorders in Children: Echoes of the 14th Congress of the Portuguese Neuropaediatrics Society". Sinapse (2020): http://dx.doi.org/10.46531/sinapse.
    10.46531/sinapse
  56. Palavra, Filipe. "Imagiologically aggressive presentation of paediatric multiple sclerosis". BMJ Case Reports (2020): http://dx.doi.org/10.1136/bcr-2019-234148.
    10.1136/bcr-2019-234148
  57. Palavra, Filipe. "Development of a Healthy Lifestyle Assessment Toolkit for the General Public". Frontiers in Medicine (2019): http://dx.doi.org/10.3389/fmed.2019.00134.
    10.3389/fmed.2019.00134
  58. Palavra, Filipe. "Unilateral facial nerve hypoplasia without evident facial palsy". BMJ Case Reports (2019): http://dx.doi.org/10.1136/bcr-2018-228036.
    10.1136/bcr-2018-228036
  59. Novo A; Castelo J; de Sousa A; Amorim I; Alves JN; Calejo M; Monteiro A; et al. "Pregnancy outcomes in Portuguese women with multiple sclerosis: The PREGNIMS study.". Multiple sclerosis and related disorders (2018): http://europepmc.org/abstract/med/30611102.
    10.1016/j.msard.2018.12.033
  60. Filipe Palavra; Conceição Robalo; Flávio Reis. "Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis Complex". Oxidative Medicine and Cellular Longevity (2017):
    10.1155/2017/9820181
  61. Palavra F. "Listeria rhombencephalitis mimicking a demyelinating event in an immunocompetent young patient.". Multiple sclerosis (Houndmills, Basingstoke, England) (2016): http://europepmc.org/abstract/med/27430682.
    10.1177/1352458516659704
  62. Ziemssen, T.; Derfuss, T.; de Stefano, N.; Giovannoni, G.; Palavra, F.; Tomic, D.; Vollmer, T.; Schippling, S.. "Optimizing treatment success in multiple sclerosis". Journal of Neurology 263 6 (2016): 1053-1065. http://www.scopus.com/inward/record.url?eid=2-s2.0-84951864477&partnerID=MN8TOARS.
    10.1007/s00415-015-7986-y
  63. Palavra, F.; Almeida, L.; Ambrósio, A.F.; Reis, F.. "Obesity and brain inflammation: A focus on multiple sclerosis". Obesity Reviews 17 3 (2016): 211-224. http://www.scopus.com/inward/record.url?eid=2-s2.0-84958917188&partnerID=MN8TOARS.
    10.1111/obr.12363
  64. Tintore M; Rovira À; Río J; Otero-Romero S; Arrambide G; Tur C; Comabella M; et al. "Defining high, medium and low impact prognostic factors for developing multiple sclerosis.". (2015): http://europepmc.org/abstract/med/25902415.
    10.1093/brain/awv105
  65. Mitsikostas DD; Ashina M; Craven A; Diener HC; Goadsby PJ; Ferrari MD; Lampl C; et al. "European Headache Federation consensus on technical investigation for primary headache disorders.". The journal of headache and pain (2015): http://europepmc.org/abstract/med/26857820.
    10.1186/s10194-016-0596-y
  66. Palavra, F.. "Monoclonal antibodies for multiple sclerosis treatment | Anticorpos Monoclonais para Tratamento da Esclerose Múltipla". Acta Medica Portuguesa 28 5 (2015): 640-651. http://www.scopus.com/inward/record.url?eid=2-s2.0-84946036493&partnerID=MN8TOARS.
  67. Negrotto, L.; Tur, C.; Tintoré, M.; Arrambide, G.; Sastre-Garriga, J.; Río, J.; Comabella, M.; et al. "Should we systematically test patients with clinically isolated syndrome for auto-antibodies?". Multiple Sclerosis 21 14 (2015): 1802-1810. http://www.scopus.com/inward/record.url?eid=2-s2.0-84948170563&partnerID=MN8TOARS.
    10.1177/1352458515575338
  68. Sousa L; de Sa J; Sa MJ; Cerqueira JJ; Martins-Silva A; Portugal Experience with Natalizumab Study Group. "The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study.". Revista de neurologia (2014): http://europepmc.org/abstract/med/25342053.
  69. Palavra F. "The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): A single case report follow-up study.". (2014): http://europepmc.org/abstract/med/24619934.
    10.1177/1352458514527024
  70. Palavra, F.; Tur, C.; Tintoré, M.; Rovira, À.; Montalban, X.. "Secondary progression is not the only explanation | A progressão secundária não é a única explicação". Acta Medica Portuguesa 27 3 (2014): 393-396. http://www.scopus.com/inward/record.url?eid=2-s2.0-84903792075&partnerID=MN8TOARS.
  71. Mascarenhas-Melo, F.; Palavra, F.; Marado, D.; Sereno, J.; Teixeira-Lemos, E.; Freitas, I.; Isabel-Mendonça, M.; et al. "Emergent biomarkers of residual cardiovascular risk in patients with low HDL-c and/or high triglycerides and average LDL-c concentrations: Focus on HDL subpopulations, oxidized LDL, adiponectin, and uric acid". The Scientific World Journal 2013 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84888877710&partnerID=MN8TOARS.
    10.1155/2013/387849
  72. Mascarenhas-Melo, F.; Sereno, J.; Teixeira-Lemos, E.; Marado, D.; Palavra, F.; Pinto, R.; Rocha-Pereira, P.; Teixeira, F.; Reis, F.. "Implication of low HDL-c levels in patients with average LDL-c levels: A focus on oxidized LDL, large HDL subpopulation, and adiponectin". Mediators of Inflammation 2013 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84887385092&partnerID=MN8TOARS.
    10.1155/2013/612038
  73. Palavra, F.. "Alemtuzumab in the treatment of multiple sclerosis: A review of efficacy and safety data | Alemtuzumab no tratamento da esclerose múltipla: Revisão dos dados de eficácia e segurança". Sinapse 13 2 (2013): 14-20. http://www.scopus.com/inward/record.url?eid=2-s2.0-84888241372&partnerID=MN8TOARS.
  74. Palavra, F.; Sallén, M.; Soler, S.; Martín, I.; Nos, C.. "Clinical outcomes in multiple sclerosis trials - Where are we and where are we going to? | Objectivos clínicos em ensaios de esclerose múltipla - Onde estamos e para onde vamos?". Sinapse 13 2 (2013): 21-26. http://www.scopus.com/inward/record.url?eid=2-s2.0-84888217591&partnerID=MN8TOARS.
  75. Figueira, C.; Palavra, F.; Guilherme, A.; Melo-Pires, M.; Gonçalves, G.. "McArdle's disease and multiple sclerosis - Rare association of two diseases McArdle's disease and multiple sclerosis - A rare association | Doença de McArdle e esclerose múltipla - Associação rara de duas doenças McArdle's disease and multiple sclerosis - A rare association". Sinapse 13 1 (2013): 39-43. http://www.scopus.com/inward/record.url?eid=2-s2.0-84877765659&partnerID=MN8TOARS.
  76. Palavra, F.; Marado, D.; Mascarenhas-Melo, F.; Sereno, J.; Teixeira-Lemos, E.; Nunes, C.C.; Gonçalves, G.; Teixeira, F.; Reis, F.. "New markers of early cardiovascular risk in multiple sclerosis patients: Oxidized-LDL correlates with clinical staging". Disease Markers 34 5 (2013): 341-348. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878866094&partnerID=MN8TOARS.
    10.3233/DMA-130979
  77. Mascarenhas-Melo, F.; Marado, D.; Palavra, F.; Sereno, J.; Coelho, T.; Pinto, R.; Teixeira-Lemos, E.; Teixeira, F.; Reis, F.. "Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women". Cardiovascular Diabetology 12 1 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84875878475&partnerID=MN8TOARS.
    10.1186/1475-2840-12-61
  78. Costa, B.L.; Duarte, J.N.; Palavra, F.; Alves, J.; Rocha, A.. "Intramedullary cavernous malformation: A rare cause of myelopathy | Malformação cavernosa intramedular cervical: Uma causa rara de mielopatia". Sinapse 12 1 (2012): 22-25. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863797646&partnerID=MN8TOARS.
  79. Palavra, F.; Gomes, B.; Gens, H.; Luzeiro, I.. "Electroencephalograms in patients with headaches: A casuistic analysis | Electroencefalogramas em doentes com cefaleias: Uma análise casuística". Sinapse 11 1 (2011): 46-50. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052915345&partnerID=MN8TOARS.
  80. Palavra, F.; Duarte, C.; Inês, L.; Gens, H.; Luzeiro, I.; da Silva, P.. "Headache in systemic lupus erythematosus: Is there an association with disease activity? | Cefaleias em doentes com lúpus eritematoso sistémico: Existe relação com a actividade da doença auto-imune?". Sinapse 11 2 (2011): 5-9. http://www.scopus.com/inward/record.url?eid=2-s2.0-84865466831&partnerID=MN8TOARS.
  81. Palavra, F.; Leitão, A.; Nunes, C.C.; Rebelo, O.. "Sub-acute white matter lesions: A diagnostic challenge | Lesões sub-agudas da substância branca: Um desafio diagnóstic". Sinapse 11 1 (2011): 25-30. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052879400&partnerID=MN8TOARS.
  82. Palavra, F.; Nunes, C.C.; Marado, D.; Campos, M.J.; Pina, R.. "Multiple sclerosis and ulcerative colitis: What association? | Esclerose múltipla e colite ulcerosa: Que associação?". Sinapse 11 1 (2011): 20-24. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052894179&partnerID=MN8TOARS.
  83. Pérez-Miralles, F.C.; Palavra, F.; Montalban, X.. "Early identification of clinically isolated syndrome - How this is best achieved and the implications for patient outcomes". European Neurological Review 5 2 (2010): 90-94. http://www.scopus.com/inward/record.url?eid=2-s2.0-84858315730&partnerID=MN8TOARS.
  84. Palavra, F.; Gens, H.; Fernandes, C.; Pombo, H.; Gonçalves, G.. "Healthcare associated infection: Emerging problem in a neurology department | Infecção associada aos cuidados de saúde: Problema emergente num serviço de neurologia". Acta Medica Portuguesa 23 4 (2010): 613-624. http://www.scopus.com/inward/record.url?eid=2-s2.0-78349282700&partnerID=MN8TOARS.
Livro
  1. Palavra, F.; Ambrósio, A.F.; Reis, F.. mTOR and Neuroinflammation. 2016.
    10.1016/B978-0-12-802733-2.00002-5
  2. Palavra, F.; Díaz, E.C.; Sena, A.. Cardiometabolic risk, inflammation, and neurodegenerative disorder. 2015.
    10.1007/978-3-319-16018-4_7
  3. Palavra, F.; Reis, F.; Marado, D.; Sena, A.. Preface. 2015.
    10.1007/978-3-319-16018-4
  4. Reis, F.; Palavra, F.. Inflammation biomarkers and cardiometabolic risk. 2015.
    10.1007/978-3-319-16018-4_1
Pré-impressão
  1. Pinto AM; Geenen R; Palavra F; Lumley MA; Ablin JN; Amris K; Branco J; et al. "An Updated Overview of the Neurophysiological and Psychosocial Dimensions of Fibromyalgia – A Call for an Integrative Model". 2020. http://europepmc.org/abstract/PPR/PPR186781.
    10.20944/preprints202007.0224.v1